Clinical Trial Update: Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update describes a multicenter assessment of using PET/MR with the radiotracer 68Ga-PSMA-11 to guide therapy planning in prostate cancer, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Medical University of Bialystok | Conditions: Prostate Cancer | NA | Status: RECRUITING